Scilex Holding Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
This press release is being made pursuant to, and in accordance with, Rule 135 under the Securities Act of 1933, as amended (the "Securities Act"), and shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act.
Media and Investor Relations
Source: Sorrento Therapeutics, Inc.